title: [Targeting Ca(v)3.2 T-type calcium channels as a therapeutic strategy for chemotherapy-induced neuropathic pain].
authors: kawabata@phar.kindai.ac.jp
authors: Atsufumi
authors: A
authors: Kawabata
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001205:Ascorbic Acid / Q000494:pharmacology; D020747:Calcium Channels, T-Type / Q000187:drug effects* / Q000502:physiology; D015232:Dinoprostone / Q000494:pharmacology; D006801:Humans; D006862:Hydrogen Sulfide / Q000494:pharmacology; D058990:Molecular Targeted Therapy; D009437:Neuralgia / Q000139:chemically induced* / Q000188:drug therapy*; D017239:Paclitaxel / Q000009:adverse effects; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced / Q000188:drug therapy
chemical_list: D000970:Antineoplastic Agents; D020747:Calcium Channels, T-Type; D015232:Dinoprostone; D017239:Paclitaxel; D001205:Ascorbic Acid; D006862:Hydrogen Sulfide